Aug 2026
The economic impact of opportunistic PSA screening: a real-world cost analysis from China amid evolving policy landscape.
BACKGROUND The clinical value of prostate-specific antigen (PSA) screening remains debated, and health economic evidence from real-world Chinese screening programs is lacking. This study aimed to determine whether PSA screening reduces prostate cancer treatment costs in China. RESEARCH DESIGN AND METHODS Using propen...
Zhehan Lin, Wei Li, Peng-Cheng Hu et al.
· Expert review of pharmacoeco... · 0 citations